About us

Creating a world where people no longer suffer from neuropsychiatric illness

Jump to
Background
Leadership
Advisors
Investors
Background

Our Background

Transcend Therapeutics, founded in 2021, is a clinical-stage, neuroscience-focused company developing rapid-acting treatments for neuropsychiatric diseases. Our mission is to develop new drugs for the millions of people for whom current psychiatric medicines have not worked.

We are developing TSND-201 (methylone) as a rapid-acting and durable treatment for Post-Traumatic Stress Disorder (PTSD), Major Depressive Disorder (MDD), and other Central Nervous System (CNS) indications.

Leadership

Our Leadership Team

Our leadership team has made pivotal contributions to 13 FDA approvals and $7B in M&A and public company value.
Kevin Ryan

Kevin Ryan

Co-founder and Chairman
Blake Mandell

Blake Mandell

Co-founder and CEO
Benjamin Kelmendi, MD

Benjamin Kelmendi, MD

Co-founder and Chief Scientific Advisor
Martin Stogniew, PhD

Martin Stogniew, PhD

Chief Development Officer
Amanda Jones, PharmD

Amanda Jones, PharmD

Sr. VP, Clinical Development
Advisors

Scientific Advisory Board

World leaders in PTSD, depression and anxiety at top research institutions.
Barbara Rothbaum, PhD

Barbara Rothbaum, PhD

Emory University
Professor of Psychiatry, Director of the Trauma and Anxiety Research Program
Gerard Sanacora, MD, PhD

Gerard Sanacora, MD, PhD

Yale School of Medicine
Professor of Psychiatry, Director, Yale Depression Research Program, Co-director, Yale-NHH Interventional Psychiatry Service
Dan Iosifescu, MD

Dan Iosifescu, MD

New York University, Nathan Kline Institute
Professor of Psychiatry NYU; Director of Clinical Research at the Nathan Kline Institute
Kerry Ressler, MD, PhD

Kerry Ressler, MD, PhD

Harvard University, McLean Hospital
Chief Scientific Officer and James & Patricia Poitras Chair in Psychiatry at McLean Hospital; Professor of Psychiatry, Harvard Medical School
Investors

Our Lead Investors

Read More
Alpha Wave Learn More
Read More
Integrated Learn More
Read More
AlleyCorp Learn More